Lamea Oncology/Anti-Cancer Drugs Market Is Expected to Reach $17.0 Billion, by 2021

A new report published by Allied Market Research titled, LAMEA Oncology/Anti-Cancer Drugs Market - Opportunities and Forecasts, 2014-2021", projects that the LAMEA oncology/cancer drugs market would reach $17.0 billion by 2021, registering a CAGR of 8.6% from 2015 to 2021. Chemotherapy segment is expected to maintain a dominant share in the LAMEA oncology/cancer drugs market during the forecast period.

Read more at: https://www.alliedmarketresearch.com/lamea-oncology-anti-cancer-drugs-market

High prevalence and rising incidence rates of major types of cancers (such as breast cancer and prostate cancer), emerging treatment algorithms and widespread use of anti-cancer drugs for treating conditions such as blood cancer (leukemia) is expected to drive this market. In addition, growing popularity of biological and targeted drug therapies, which help in improving the patients survival time, are projected to provide opportunities in the LAMEA oncology/anti-cancer drugs market. However, factors such as high cost associated with cancer drugs and related side effects are likely to affect the market growth.

Blood cancer segment is expected to maintain its dominant position throughout the forecast period. This is attributed to the higher incidence rates of blood cancer across the LAMEA region and growing awareness about the early detection and treatment of blood cancer. However, respiratory/lung cancer was the fastest growing segment registering a CAGR of 10.2% during the analysis period. Furthermore, commercialization of advanced therapeutics such as biologic therapies (immunotherapies) and targeted therapies are anticipated to increase the adoption of anti-cancer drugs in the LAMEA region.

Key findings of the study:

• Immunotherapy (biologic therapy) is projected to be the fastest growing segment, registering a CAGR of 12.2% during the forecast period.

• Chemotherapy is expected to dominate the LAMEA oncology/cancer drugs market throughout the forecast period....